Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy

[1]  C. Bokemeyer,et al.  Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. , 2009, European journal of cancer.

[2]  J. Glaspy.  Erythropoietin in cancer patients. , 2009, Annual review of medicine.

[3]  N. Soni,et al.  Ten years of hemovigilance reports of transfusion‐related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma , 2009, Transfusion.

[4]  P. Heras,et al.  Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study. , 2008, European journal of cancer care.

[5]  E. Esteban,et al.  Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapy , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[6]  S. Park,et al.  A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer , 2008, Cancer Chemotherapy and Pharmacology.

[7]  C. Bokemeyer,et al.  Erythropoietins should be used according to guidelines. , 2008, The Lancet. Oncology.

[8]  R. Pötter,et al.  Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy , 2008, Clinical Cancer Research.

[9]  N. Saijo,et al.  Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy. , 2008, Japanese journal of clinical oncology.

[10]  J. Mayordomo,et al.  Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Mathoulin-Pélissier,et al.  Epoetin beta treatment of chemotherapy induced anemia in cancer patients: Results of a large prospective cohort study , 2007 .

[12]  T. Seufferlein,et al.  Erythropoetin (epoetin beta) once weekly in anemic patients with advanced cancer of the stomach or gastroesophageal junction: Interim results of a randomized German AIO phase II trail , 2007 .

[13]  H. Burger,et al.  Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer , 2007, International Journal of Gynecologic Cancer.

[14]  M. Tsuboi,et al.  Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study. , 2006, Japanese journal of clinical oncology.

[15]  Christopher A. Seaman,et al.  Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature. , 2006, Clinical therapeutics.

[16]  C. Bokemeyer,et al.  Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey , 2006, Oncology.

[17]  P. Johnston,et al.  Cancer-Related Anemia: Biological Findings, Clinical Implications and Impact on Quality of Life , 2005, Oncology.

[18]  R. Kurtz,et al.  A multidisciplinary approach to gastrointestinal bleeding in cancer patients. , 2005, The journal of supportive oncology.

[19]  Dirk Schrijvers,et al.  The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. , 2004, European journal of cancer.

[20]  C. Rübe,et al.  Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial , 2003, The Lancet.

[21]  D. Cella,et al.  Erythropoietin improves quality of life. , 2002, The Lancet. Oncology.

[22]  J. Caro,et al.  Anemia as an independent prognostic factor for survival in patients with cancer , 2001 .

[23]  J. Groopman,et al.  Chemotherapy-induced anemia in adults: incidence and treatment. , 1999, Journal of the National Cancer Institute.

[24]  C. Helmers,et al.  Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H. Wieand,et al.  Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Burgess,et al.  Hemopoietic growth factors: a review. , 1988, Cancer research.

[27]  M. Aapro,et al.  Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: initial evidence from the RESPOND study. , 2009, European journal of cancer.

[28]  M. Somerfield,et al.  Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Bokemeyer,et al.  EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. , 2007, European journal of cancer.

[30]  G. Demetri.  Evidence-Based Use of Hematopoietic Growth Factors for Optimal Supportive Care of Patients with Cancer , 2006 .

[31]  Joon-Oh Park,et al.  Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer , 2005, Cancer Chemotherapy and Pharmacology.

[32]  K. Knight,et al.  Prevalence and outcomes of anemia in surgery: a systematic review of the literature. , 2004, The American journal of medicine.